These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9399103

  • 1. Regulatory role of CD8 in major histocompatibility complex-unrestricted tumoricidal activity of mouse T cells activated with anti-CD3 monoclonal antibody.
    Stewart BH, Hoskin DW.
    Immunol Invest; 1997; 26(5-7):601-14. PubMed ID: 9399103
    [Abstract] [Full Text] [Related]

  • 2. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
    Greene AL, Makrigiannis AP, Fitzpatrick L, Hoskin DW.
    J Interferon Cytokine Res; 1997 Dec; 17(12):727-37. PubMed ID: 9452360
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity.
    Fitzpatrick L, Makrigiannis AP, Kaiser M, Hoskin DW.
    J Interferon Cytokine Res; 1996 Jul; 16(7):537-46. PubMed ID: 8836920
    [Abstract] [Full Text] [Related]

  • 4. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of cytotoxic T cell lysis by anti-CD8 monoclonal antibodies: studies with CD3-targeted cytolysis of nominal antigen-negative targets.
    Quinones RR, Segal DM, Henkart P, Perez P, Gress RE.
    J Immunol; 1989 Apr 01; 142(7):2200-6. PubMed ID: 2466891
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP, Musgrave BL, Hoskin DW.
    J Leukoc Biol; 1999 Nov 01; 66(5):792-802. PubMed ID: 10577511
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL, Patel SS, Lipsky PE.
    J Immunol; 1988 May 01; 140(9):3253-60. PubMed ID: 2966209
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Signal requirement for induction of MHC-unrestricted antitumor cytotoxicity of human T cell CD4+/CD8+ subpopulations.
    Zhu HG, Klein-Franke A, Anderer FA.
    Anticancer Res; 1994 Jun 01; 14(3A):953-61. PubMed ID: 8074498
    [Abstract] [Full Text] [Related]

  • 16. 2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell-surface adenosine receptor.
    Hoskin DW, Reynolds T, Blay J.
    Cell Immunol; 1994 Nov 01; 159(1):85-93. PubMed ID: 7954843
    [Abstract] [Full Text] [Related]

  • 17. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J, Waks T, Eshhar Z.
    Eur J Immunol; 1991 Oct 01; 21(10):2507-15. PubMed ID: 1915555
    [Abstract] [Full Text] [Related]

  • 18. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K, Tachibana M, Suzuki H, Yamazaki S, Shinohara N.
    Eur J Immunol; 1997 Jan 01; 27(1):55-61. PubMed ID: 9021998
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
    Baume DM, Caligiuri MA, Manley TJ, Daley JF, Ritz J.
    Cell Immunol; 1990 Dec 01; 131(2):352-65. PubMed ID: 2122925
    [Abstract] [Full Text] [Related]

  • 20. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS, Hargrove ME, Ting CC.
    Cancer Res; 1989 Sep 01; 49(17):4770-4. PubMed ID: 2527087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.